2024-29602. National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting  

  • Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose ( print page 102152) confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; HHS-NIH-NIAID-SBIR PHS 2025-1 Phase 1 and Fast Track: New Drug Classes with Novel Mechanisms of Action for HIV, Hepatitis B, and Tuberculosis (Topic 137).

    Date: January 17-24, 2025.

    Time: 10:00 a.m. to 3:00 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G11, Rockville, MD 20892 (Video Assisted Meeting).

    Contact Person: Barry J. Margulies, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G11, Rockville, MD 20892, (301) 761-7956, barry.margulies@nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

    Dated: December 11, 2024.

    Lauren A. Fleck,

    Program Analyst, Office of Federal Advisory Committee Policy.

    [FR Doc. 2024-29602 Filed 12-16-24; 8:45 am]

    BILLING CODE 4140-01-P

Document Information

Published:
12/17/2024
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2024-29602
Dates:
January 17-24, 2025.
Pages:
102151-102152 (2 pages)
PDF File:
2024-29602.pdf